Lifecore Biomedical, LLC

Form 483 issued January 21, 2021 · Chaska, Minnesota

Inspection
Jan 11 – Jan 21, 2021
Observations
2
Pages
4
FEI number
1000115753

In short: On January 21, 2021, FDA issued a Form 483 with 2 observations to Lifecore Biomedical, LLC in Chaska, Minnesota (FEI 1000115753) after an inspection that ran Jan 11 – Jan 21, 2021. The investigator was Christina L. Bigham. Most observations concern production & process controls; the most-cited regulation is 21 CFR 820.75 (process validation).

At a glance

2 of 2 observations on this 483 concern production & process controls.

Production & process controls2

Most cited: 21 CFR 820.75 (1×) · 820.50 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    A process whose results cannot be fully verified by subsequent inspection and test has not been…

  2. 02

    There is no agreement with suppliers, contractors and consultants to notify you of changes in…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Lifecore Biomedical, LLC?

FDA listed 2 observations on this Form 483, mostly about production & process controls. The most-cited regulation is 21 CFR 820.75 (process validation). The opening words of each observation are shown on this page.

Who inspected Lifecore Biomedical, LLC?

Christina L. Bigham is named on this Form 483, for the inspection of Jan 11 – Jan 21, 2021. Each investigator has a profile showing what they cite most.

When was Lifecore Biomedical, LLC inspected by FDA?

The inspection ran Jan 11 – Jan 21, 2021, and the Form 483 is dated January 21, 2021.

How do I get the full Form 483 for Lifecore Biomedical, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free